Home > Press > Bionanome Releases First List of Researchers, Academics, and Executives in the Singapore Biotechnology Industry
Abstract:
Bionanome today announced the release of their first industry contact name list of all researchers, managers, academics, and others connected with the Singapore biotechnology industry. This list is targeted specifically at the researchers, executives, and suppliers who drive this important vertical market niche in Singapore, Southeast Asia's biotech center. The foresight and generous funding of the government of Singapore is catalyzing cutting-edge research at modern facilities by world-class scientists from domestic and foreign universities, corporations, and institutes.
Bionanome today announced the release of their first industry contact name list of all researchers, managers, academics, and others connected with the Singapore biotechnology industry. This list is targeted specifically at the researchers, executives, and suppliers who drive this important vertical market niche in Singapore, Southeast Asia's biotech center. The foresight and generous funding of the government of Singapore is catalyzing cutting-edge research at modern facilities by world-class scientists from domestic and foreign universities, corporations, and institutes.
Although there are numerous resources for targeting marketing campaigns at European and US industry executives in the biotech industry, an up-to-date biotech contact list is hard to find for Singapore, at least in an affordable format for a direct-mail or other sales or marketing campaigns.
"My management colleagues and I are confident that this scrupulously researched list is the best available, and it grows daily," said Bionanome president David Govett. "Meticulous research and refined information collection and verification techniques have enabled Bionanome to offer the industry's first contact list of key Singaporean personnel in the biotechnology industry."
"To be effective, a contact list must be researched carefully by experienced professionals with backgrounds in the relevant technology," said Bionanome vice-president Athol Foden. "We strive not merely to collect data, but to apply optimized management and research techniques to the development of good quality contact information attuned to the Singapore market."
####
About Bionanome
Bionanome is a privately held business research partnership that specifically targets the Asian biotechnology and nanotechnology industries. Bionanome currently offers English-language contact lists of all important people in those industries in Japan and for biotechnology in Singapore. David Govett (Senior Partner) is also the president of Japatent (http://www.japatent.com/) and has been involved with cutting-edge Japanese technology for most of his career. Athol Foden (Partner) is also the president of Brighter Naming ( http://www.brighternaming.com/ ) as well as a seasoned international marketing executive with extensive experience throughout Silicon Valley.
For more information, please click here
Contacts:
Bionanome
+1-530-757-2323
Copyright © PRWeb™
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||